Drug Database
Back to search

Ireland· IE-PA-PA2325/009/001

Naseptin 0.1% & 0.5% w/w Nasal Cream

A neomycin product containing chlorhexidine dihydrochloride + neomycin sulfate, registered in Ireland by Alliance Pharma (Ireland) Limited. The same ATC class is registered in 6 of our 19 countries.

ATC D06AX04

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedNaseptin 0.1% & 0.5% w/w Nasal CreamATCD06AX04REGISTER NO.IE-PA-PA2325/009/001PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about chlorhexidine dihydrochloride + neomycin sulfateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Neomycin is registered in 6 of 19 countries.

Countries holding a registration under ATC D06AX04 (neomycin), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 3 of them publish a price we can compare per daily dose
Search neomycin products by name

Neomycin · ATC D06AX04

6 / 19 countries

  • Finlandprice
  • Germany
  • Ireland
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Chlorhexidine Dihydrochloride + Neomycin sulfate
Manufacturer
Alliance Pharma (Ireland) Limited
Country
Ireland (IE)
ATC code
D06AX04
ATC class
Neomycin
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA2325/009/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

19 interactions on record for neomycin.

Graded by severity as the source publishes them — 19 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check neomycin against other medicinesHow interaction checks work

Neomycin · interactions on record

19 records

  • 19 moderate

Most severe, free to view

  • StreptomycinA07AA04moderate
  • KanamycinA07AA08moderate
  • StreptomycinJ01GA01moderate
  • TobramycinJ01GB01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under D06AX04

Neomycin, as other registers publish it.

All neomycin products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • United Kingdom (Northern Ireland) · Naseptin Nasal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fb4b0945-35d8-4df1-aae9-3d31682776e1
GET /v1/drugs/fb4b0945-35d8-4df1-aae9-3d31682776e1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Nasal cream",
  "routes": [
    "Subcutaneous use"
  ],
  "source": "hpra",
  "atc_all": [
    "D06AX",
    "D06AX04"
  ],
  "strength": null,
  "pa_number": "PA2325/009/001",
  "substances": [
    "Chlorhexidine Dihydrochloride",
    "Neomycin sulfate"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "01/04/1998",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about neomycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console